Keeping Current CME Podcast
1) Breaking Ground in Gastroesophageal Adenocarcinoma: First-Line Anti-HER2 Therapy for Advanced Disease
Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 02/27/2027 Earn Credit / Learn...Show More
2) Chronic Lymphocytic Leukemia (CLL): Review of Combination Approaches
Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights.  Credit available for this activity e...Show More
3) Quick Talk on ES-SCLC: What Community Clinicians Need to Know Now
Are you up to date on the management of extensive-stage small cell lung cancer (ES-SCLC)? Credit available for this activity expires: 2/20/27 Earn Credit / Learning Objectives & Disclosures: https://w...Show More
4) Best Practices for Integrating Biosimilars Into Clinical Practice: An Interprofessional Perspective
Clear communication builds trust in biosimilars. Credit available for this activity expires: 2/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003245?ecd=...Show More
5) CAR T Cells in SLE: A New Frontier in Autoimmunity
Early evidence for CAR T-cell therapy in lupus is compelling. Are you up-to-date? Credit available for this activity expires: 2/9/26 Earn Credit / Learning Objectives & Disclosures: https://www.medsca...Show More
6) Case by Case: Managing ES-SCLC in the Real World Through Patient Partnership
Are you up to date with the latest management for extensive-stage small cell lung cancer? Credit available for this activity expires: 2/11/27 Earn Credit / Learning Objectives & Disclosures: https://...Show More
7) Utilizing Automated Insulin Delivery to Close Gaps in Type 2 Diabetes Care
How can AID close gaps in T2D care and help you personalize evidence-based AID for real-world practice? Credit available for this activity expires: 1/30/27 Earn Credit / Learning Objectives & Disclosu...Show More
8) Empowering Choices in Moderate to Severe Asthma: Partnering With Patients for Optimal Treatment Decisions
Shared decision-making isn't just a buzzword—it's the key to better adherence, fewer exacerbations, and improved quality of life for your patients. Credit available for this activity expires: [01/30/2...Show More
9) Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data
Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases? Credit available for this activity expires: 1/26/27 Earn Cre...Show More
10) COPD Device Decisions That Matter: Who Really Benefits From Nebulized Therapy?
Inhaler technique errors are common—learn how to spot them and when to consider switching to nebulized therapy for optimal chronic obstructive pulmonary disease (COPD) care. Credit available for this ...Show More